CorRELation Between PatIent PErception and Findings on Clinical Examination (RELIEF)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a multi-center, prospective, non-interventional study that aims to evaluate in daily clinical practice, the possible corelation between patIent perception of the ability to perform morning activities and physician evaluation; patients with COPD, grade C and D.
| Condition |
|---|
|
Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | CorRELation Between PatIent PErception of the Ability to Perform Morning Activities and Findings on Clinical Examination in COPD Patients |
- Change from baseline in Capacity of Daily Living during the Morning (CDLM) Questionnaire [ Time Frame: Baseline and 3 months ] [ Designated as safety issue: No ]CDLM questionnaire is a simple self-reporting tool of the burden and ability of COPD patients to perform routine morning activities: washing, dressing, eating breakfast, walking around. For each of these morning activities the score is varying from 0 (indicating worst case) to 5 (indicating best case).
- Change from baseline of patient's general health status based upon physician evaluation - visual scale [ Time Frame: Baseline and 3 months ] [ Designated as safety issue: No ]General health status visual scale is assessing the physicians perception of the patient health status following the clinical examination. Based upon clinical evaluation, the physician will indicate the patient's general condition on a a scale consisting of 5 levels. The scale will be completed at each visit and the score can vary from 1(very bad general health status) to 5 (very good general health status) .
- Demographic patient characteristics [ Time Frame: Day 0 (visit1) ] [ Designated as safety issue: No ]
Demographic patient characteristics are:
Age (years), gender (male/female), weight (kg), height (cm), place of origin (urban, rural)
- Patient adherence to treatment - visual scale [ Time Frame: up to 3 months ] [ Designated as safety issue: No ]
The physician will evaluate adherence to treatment, after discussion with patient, by completing a visual scale for evaluation patient's adherence to treatment (adherence will be assessed in percentage, by indicating at the scale the value from 0% to 100% adherence).
The visual scale has the following cut-off points: 0% (no adherence to treatment), 25% (poor adherence), 50% (medium adherence), 75% (good adherence), 100% (high adherence).
- Number of daily walking steps (using pedometer) [ Time Frame: up to 3 months ] [ Designated as safety issue: No ]The pedometers register the total daily walking steps. Each morning, the subject will reset the device by pressing the on/reset button. At the end of the day, the patient will record the number of daily walking steps. The estimated value for number of walking steps is 2,500 - 4,500 steps/day (based on previous studies).
- Number of exacerbations [ Time Frame: up to 3 months ] [ Designated as safety issue: No ]Exacerbation is defined as a worsening of COPD symptoms that is beyond day-to-day variations and that requires antibiotic treatment and/or short systemic corticoid treatment and/or emergency room visit with or without hospital admission (according to GOLD criteria and previous studies).
| Enrollment: | 505 |
| Study Start Date: | July 2012 |
| Study Completion Date: | January 2013 |
| Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| COPD patients grade C and D |
Detailed Description:
CorRELation between PatIent PErception of the Ability to Perform Morning Activities and Findings on Clinical Examination in COPD Patients
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
COPD patients, group C and D according to GOLD guidelines 2011, being treated for at least 1 month with combination ICS/LABA treatment
Inclusion Criteria:
- Diagnosis of COPD, grade C and D according to GOLD Guidelines Revised 2011
- Current or past smokers, of at least 10 pack years
- Receive any inhaled combination therapy for COPD (inhaled corticosteroid / long acting β2-agonist bronchodilator) initiated for at least one month before entering in the study
Exclusion Criteria:
- History of exacerbation of COPD symptoms within the last month before visit 1, inclusive; history of asthma or allergic rhinitis; history of lung carcinoma or any other respiratory condition that may limit the airflow circulation
- Inability to understand study procedures and inability/refuse to complete CDLM questionnaires and/or record the values showed on the pedometer screen
Contacts and Locations| Romania | |
| Research Site | |
| Bacau, Romania | |
| Research Site | |
| Botosani, Romania | |
| Research Site | |
| Bucuresti, Romania | |
| Research Site | |
| Buzau, Romania | |
| Research Site | |
| Calarasi, Romania | |
| Research Site | |
| Cluj-Napoca, Romania | |
| Research Site | |
| Constanta, Romania | |
| Research Site | |
| Craiova, Romania | |
| Research Site | |
| Drobeta Turnu Severin, Romania | |
| Research Site | |
| Falticeni, Romania | |
| Research Site | |
| Focsani, Romania | |
| Research Site | |
| Iasi, Romania | |
| Research Site | |
| Leordeni, Romania | |
| Research Site | |
| Ludus, Romania | |
| Research Site | |
| Oradea, Romania | |
| Research Site | |
| Ploiesti, Romania | |
| Research Site | |
| Ramnicu Valcea, Romania | |
| Research Site | |
| Reghin, Romania | |
| Research Site | |
| Slatina, Romania | |
| Principal Investigator: | Florin Mihaltan, PROFESSOR | University of Medicine and Pharmacy Carol Davila, Bucharest, Romania |
More Information
No publications provided
| Responsible Party: | AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT01627743 History of Changes |
| Other Study ID Numbers: | NIS-RRO-ATC-2012/1 |
| Study First Received: | June 22, 2012 |
| Last Updated: | February 20, 2013 |
| Health Authority: | Romania: Ethics Committee Romania: National Agency for Medicines and Medical Devices |
Keywords provided by AstraZeneca:
|
CDLM visual scale - physician evaluation COPD GOLD group C and D |
Additional relevant MeSH terms:
|
Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 19, 2013